December 8 Decembre, 2016

December 08, 2016

Bonjour-Hi!

In today’s news/Dans les manchettes aujourd'hui: The Toronto board of health asks Ottawa to allow pharmacies to dispense medical cannabis as the VP of London Drugs says his chain is ready to start serving patients. The Globe and Mail questions whether Canada could become the first case study on the benefits of legal grass and The Guardian explores how the creative world is allowing legal weed to rebrand itself. CannaRoyalty becomes another cannabis company to list on a Canadian stock exchange and TIME looks at seven reasons Trump’s presidency doesn’t mean the sky is falling on reform, chicken little. Also, sources in North Korea say Chinese tourists are buying bargain bags of grass from the rogue state, the NBA is reported to be reaching a tipping point on the cannabis file, and visit the village of Malana in the Indian Himalayas, where marijuana is the only livelihood. Have a great day!

Canopy Growth
Meet The Grower: Clark uprooted his life to chase down a dream of working with weed

Legalization/Légalisation
Could Canada serve as the first national case study on the benefits and dangers of legal pot?
TIME lists seven reasons President Donald Trump is unlikely to derail the legal pot train

Industry/Industrie
Toronto board of health asks Trudeau government to allow pharmacies to dispense med pot
London Drugs VP says his pharmacy chain is ready to start dispensing medical cannabis
Investors gain access to CannaRoyalty with new public listing on the CSE
High art: The Guardian explores how the creative world is helping legal weed rebrand itself

General Interest/Divers
Sources say that Chinese tourists to North Korea are buying bargain bags of marijuana
Merry Jane looks at how to get high at the office holiday party and not ruin your career
PBS New Hour explores the long and tumultuous history of the war on weed in the U.S.
Visit the village of Malana in the Indian Himalayas, where cannabis is the only livelihood
Americans For Safe Access are legally challenging the DEA’s misinformation about pot
The NBA is beginning to reach a tipping point in the debate over the league’s cannabis use